Roivant Sciences Ltd.

NasdaqGS:ROIV

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💄 Cosmetics

Location

United Kingdom

Market Cap

USD 7.78 B

Share Price

USD 11.45

Avg Daily Volume

6,663,046

Change (1 day)

0.09%

Change (1 year)

6.02%

Change (YTD)

-3.21%

Roivant Sciences Ltd. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 591.41 M

Roivant Sciences Ltd. Selling, General, and Administrative Expenses (SG&A) is USD 591.41 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -13.00% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.

Roivant Sciences Ltd. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 679.77 M.
Roivant Sciences Ltd. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 285.52 M.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Selling, General, and Administrative Expenses (SG&A)	Research and Development (R&D) Expenses	Revenue	Revenue

NasdaqGS: ROIV

Roivant Sciences Ltd.

CEO	Mr. Matthew Gline
IPO Date	Dec. 8, 2020
Location	United Kingdom
Headquarters	11-12 St. James's Square
Employees	908
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💄 Cosmetics

Description

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.